Cashu Logo
HomeWatchlistNewsSignalsPicks
DJI
+0.08%
SPX
-0.22%
IXIC
-0.51%
FTSE
-0.20%
N225
-0.22%
AXJO
-0.21%
Cashu Logo
Log In
HomeWatchlistNewsSignalsPicks
Stocks
0.00 (0.00%)
0.000
USD
At close at --,----
Cashu Logo Alt
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.

Company

  • About Us
  • Careers
  • Blog
  • News

Help & Support

  • Help Center
  • Contact Us
  • Pro Support

Legal

  • Privacy Policy
  • Terms of Use
InstagramYouTube

© 2024 Cashu PTY LTD.

Overview

Loading chart...
Join our newsletter to keep up to date with us!

Key Stats

Market Cap
206.23M
Dividend Yield
0.00%
P/E Ratio
-4.22
EPS
-0.94
Revenue
684.00K
Avg. Volume
689.75K

Recently from Cashu

publisher logo
Cashu

Cardiff Oncology Expands Onvansertib Trials for Innovative Cancer Treatments

1 day ago
publisher logo
Cashu

Cardiff Oncology's Onvansertib Shows Promising Results in Metastatic Colorectal Cancer Trials

3 days ago

About

What does CRDF do?
Cardiff Oncology, based in San Diego, develops drugs targeting mitosis for cancer treatment, focusing on PLK1 inhibition. Its lead candidate, Onvansertib, is undergoing five clinical trials for various cancers.
Sector
💻 Health Care
IPO
CEO
Employees
Headquarters
California, USA
Website
http://www.cardiffoncology.com
Stocks
Health Care
crdf
Cardiff Oncology
CRDF
+0.08 (+2.65%)
3.1
USD
At close at Jun 20, 20:40 UTC
Summary
News
Signals
Benchmarks
Financials